Skip to content

Clinical trials

Hepatitis C, Chronic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Country / region: Germany Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20041
20054
20064
20078
20087
20095
20108
201114
201217
20135
20143
20152
20163
20175
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Terminated5
Unknown status3
Active, not recruiting1
No longer available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche21
Boehringer Ingelheim11
Gilead Sciences8
AbbVie6
Debiopharm International SA5
GlaxoSmithKline4
Janssen-Cilag International NV4
Human Genome Sciences Inc.3
Vertex Pharmaceuticals Incorporated3
Janssen R&D Ireland2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic93
Hepatitis C31
Hepatitis5
Liver Diseases5
Infections4
Virus Diseases4
Fibrosis3
Hepatitis, Viral, Human3
Hepatitis, Chronic2
Acquired Immunodeficiency Syndrome1

Trials

Showing 26 to 50 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.